Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial

Clive Ballard , Marisa Margallo-Lana , Edmund Juszczak , Simon Douglas
BMJ 330 ( 7496) 874 -874

243
2005
Genetic Organization of the Region Encoding Regulation, Biosynthesis, and Transport of Rhizobactin 1021, a Siderophore Produced by Sinorhizobium meliloti

Damien Lynch , John O'Brien , Timothy Welch , Paul Clarke
Journal of Bacteriology 183 ( 8) 2576 -2585

159
2001
Divergent functional connectivity during attentional processing in Lewy body dementia and Alzheimer's disease.

Xenia Kobeleva , Michael Firbank , Luis Peraza , Peter Gallagher
Cortex 92 8 -18

38
2017
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial

Sube Banerjee , Jennifer Hellier , Michael Dewey , Renee Romeo
The Lancet 378 ( 9789) 403 -411

327
2011
A 1-year follow-up study of behavioral and psychological symptoms in dementia among people in care environments

Clive G. Ballard , Marisa Margallo-Lana , Jane Fossey , Katharina Reichelt
The Journal of Clinical Psychiatry 62 ( 8) 631 -636

140
2001
The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: Evidence of validity

Giovanni B Frisoni , Clifford R Jack Jr , Martina Bocchetta , Corinna Bauer
Alzheimers & Dementia 11 ( 2) 111 -125

133
2015
THE EVALUATION OF MTOR PATHWAY DYSREGULATION AS A NOVEL BLOOD-BASED PHENOTYPIC RISK BIOMARKER FOR THE ASSESSMENT OF ALZHEIMER'S DISEASE AND DEMENTIA

Harald Juergen Hampel , Bruno Dubois , Ian McKeith , John O'Brien
Alzheimers & Dementia 10 ( 4) 283

2014
Relevant clinical outcomes in probable vascular dementia and Alzheimer's disease with cerebrovascular disease.

John O'Brien , Sean Lilienfeld
Journal of the Neurological Sciences 203 41 -48

9
2002
Brief Psychosocial Therapy for the Treatment of Agitation in Alzheimer Disease (The CALM-AD Trial)

Clive Ballard , Richard Brown , Jane Fossey , Simon Douglas
American Journal of Geriatric Psychiatry 17 ( 9) 726 -733

64
2009
Dementia with Lewy Bodies

Ian McKeith , John O'Brien
Australian and New Zealand Journal of Psychiatry 33 ( 6) 800 -808

27
1999
End of life treatment decisions in people with dementia: carers' views and the factors which influence them

Dawn Potkins , Sonia Bradley , Jay Shrimanker , John O'Brien
International Journal of Geriatric Psychiatry 15 ( 11) 1005 -1008

26
2000
36
2009
Medial temporal lobe volumes on MRI and neuropathology in autopsy-confirmed Lewy body dementia

Emma Burton , Elizabeta Mukaetova-Ladinska , Robert Perry , Evelyn Jaros
Alzheimers & Dementia 7 ( 4)

2011
Electromagnetic modeling of wafer-level silicon electro-optical packages for 10 & 40 Gb/s communications

Kenneth Vanhille , John O'Brien , David Sherrer , William Hogan
european microwave conference 599 -602

1
2007
Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology.

Alistair Burns , John O'Brien ,
Journal of Psychopharmacology 20 ( 6) 732 -755

121
2006
A Detailed Phenomenological Comparison of Complex Visual Hallucinations in Dementia With Lewy Bodies and Alzheimer's Disease

Clive Ballard , Ian McKeith , Richard Harrison , John O'Brien
International Psychogeriatrics 9 ( 4) 381 -388

57
1997